University of California San Francisco
Give to UCSF
Funded through President Obama's Brain Initiative, a UCSF-led team is embarking on a $26 million project to develop a revolutionary and long-lasting treatment for depression, anxiety disorders, addiction and other neuropsychiatric disorders.
UCSF's Peter Walter has received Asia’s highest scientific honor, the 2014 Shaw Prize in Life Science and Medicine, for his groundbreaking discovery of a cellular system that makes “life and death decisions” for the cell.
UCSF cell biologist Torsten Wittmann, PhD, has just made a key discovery of a molecular process that is a lynchpin in permitting the directional movement of cells.
Researchers at UCSF, UC Berkeley and partner institutions are receiving $6 million to help address three neglected tropical diseases that place a huge health and economic burden on people in Central and South America: Chagas’ disease, dengue and onchocerciasis.
Researchers from UCSF played major roles in five significant multicenter studies of lung disease published in The New England Journal of Medicine.
Harvey V. Fineberg, MD, PhD, MPP, the President of the Institute of Medicine, will come to UCSF for a yearlong appointment as a Presidential Chair beginning in September.
As UC San Francisco marks 150 years as a medical college, it looks ahead to leading the next revolutions in health, education and science.
UCSF scientists have found that industry claims about e-cigarettes are unsupported by the evidence to date, including claims that they help smokers quit.
Deadly skin cancers in mice shrank in response to a new treatment that may complement other “immunotherapies” developed recently to boost the body’s own defenses against disease threats, according to a new study published by UCSF researchers.
A scientific team led by the Gladstone Institutes and UCSF has discovered that a common form of a gene already associated with long life also improves learning and memory.
Two from UCSF, Frank McCormick, PhD, FRS, and Jason G. Cyster, PhD, have been selected as members of the National Academy of Sciences, one of the highest honors that can be accorded an American scientist.
The Food and Drug Administration has selected UCSF as the site of a new regulatory science center on the West Coast. The center aims to spur innovative approaches in drug development that will support the FDA’s ability to evaluate and approve safe and effective new medications.
Young blood really does rejuvenate the brain, at least in mice, raising hopes that molecules in the blood may be identified that can do the same for humans, according to a new UCSF study.
New pharmaceuticals to fight autoimmune diseases, such as multiple sclerosis, rheumatoid arthritis and psoriasis, may be identified more effectively by adding genome analysis to standard drug screening, according to a new study by a research team led by UC San Francisco and Harvard researchers.